Thrombin-Derived C-Terminal Peptide Reduces Candida-Induced Inflammation and Infection In Vitro and In Vivo

Infections due to the opportunistic fungus Candida have been on the rise in the last decades, especially in immunocompromised individuals and hospital settings. Unfortunately, the treatments available today are limited. Thrombin-derived C-terminal peptide (TCP-25) is an antimicrobial peptide (AMP) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlman, Anna, Puthia, Manoj, Petrlova, Jitka, Schmidtchen, Artur, Petruk, Ganna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522777/
https://www.ncbi.nlm.nih.gov/pubmed/34424043
http://dx.doi.org/10.1128/AAC.01032-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522777/
https://www.ncbi.nlm.nih.gov/pubmed/34424043
http://dx.doi.org/10.1128/AAC.01032-21

Ejemplares similares